Japan In-Vitro Diagnostics Market Growth, Trends, Share, Revenue, Challenges, Future Outlook

Japan In-Vitro Diagnostics Market Size - By Product, By Test Type, By Usability, By Application - Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Japan In-Vitro Diagnostics Market Size - By Product, By Test Type, By Usability, By Application - Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Published: Jul 2024 Report ID: HLCA2465 Pages: 1 - 104 Formats*:     
Category : Healthcare
Japan In-Vitro Diagnostics Market Introduction and Overview 

According to SPER Market Research, the Japan In-Vitro Diagnostics Market is estimated to reach USD 6.70 Billion by 2033 with a CAGR of 2.58%.

The report includes an in-depth analysis of the Japan In-Vitro Diagnostics Market, encompassing product mix, applications, supplier analysis, market size and trends. In vitro diagnostics (IVD) refers to a set of medical tests done on biological samples from the human body. These tests identify illnesses, infections, and other medical disorders by analysing blood, urine, or tissue samples from outside the living organism. They are used in laboratories, hospitals, and specialised clinics and are essential for medical decision-making, patient monitoring, and personalised treatment. The growing use of IVD in healthcare promotes early diagnosis and accurate therapy, allowing providers to make more informed and timely decisions. As a key component of modern healthcare systems, IVD advances preventive and therapeutic care, improving overall patient well-being.

  • In January 2024, bioMerieux announced the acquisition of LUMED, a software startup that created a clinical decision support system to help hospitals optimise antibiotic prescriptions and track healthcare-associated illnesses.
  • Sysmex Corporation stated in August 2023 that Roche Diagnostics International Ltd. would be included in the Global Business Partnership Agreement (GBPA).
  • In April 2023, Oxford Nanopore Technologies plc and bioMerieux SA formed a partnership to improve global health outcomes by pursuing specific opportunities to deliver nanopore sequencing to the infectious illness diagnosis market.
  • Sysmex and Fujirebio signed a commercial collaboration agreement in the field of immunoassay in October 2023, with the goal of encouraging cooperation to accelerate their global expansion and contributing to the development and progress of immunoassay technology.
Japan In-Vitro Diagnostics Market
Market Opportunities and Challenges

Opportunities- The growing elderly population need more comprehensive and routine medical testing, which is one of the primary reasons driving market growth. In accordance with this, the rising frequency of age-related disorders such as diabetes, cardiovascular disease, and cancer, which necessitates more IVD tests to detect and manage these ailments, is driving market growth. Furthermore, rapid technological advancements in IVD are introducing innovative solutions with higher accuracy and efficiency, such as innovations in molecular diagnostics, point-of-care (POC) testing, and automation technologies, which improve the precision, speed, and accessibility of IVD tests, creating a positive outlook for market growth. Furthermore, the growing number of government programmes fostering healthcare innovation, as well as the advent of user-friendly, personalised IVD solutions, are boosting market growth. Furthermore, as consumers become more proactive in maintaining their health, there is an increase in demand for wellness-related diagnostic tests and personalised medicine solutions, which is driving growth.

Challenges- The Japanese in-vitro diagnostics market is being restrained by the absence of a suitable payment system, strict regulations, and tight budgets of hospitals and laboratories in emerging nations. Furthermore, the lack of qualified laboratory personnel, the expensive price of sophisticated molecular diagnostics and in vitro diagnostics equipment, and the onerous premarket approval (PMA) and IVD labelling regulations will also hinder the market's expansion.

Japan In-Vitro Diagnostics Market


Market Competitive Landscape
The industry is dominated by big market players, who are also investing much in research and development to create a stable and safe formulation. For the past few years, the market has noticed large-scale technological improvements. For example, in July 2017, Sysmex Corporation and bioMérieux announced an agreement to transfer all of Sysmex's assets in Sysmex bioMérieux Co., Ltd. (Tokyo, Japan) to bioMérieux. Biomérieux, Abbott Laboratories, Bayer AG, Bio-Rad Laboratories, Inc, Danaher Corporation, Johnson & Johnson, Nippon Becton Dickinson Company, Roche Diagnostics, and Siemens are among the major competitors in Japan's in-vitro diagnostics market.

Scope of the Report:
 Report Metric Details
 Market size available for years 2020-2033
 Base year considered 2023
 Forecast period 2024-2033
 Segments coveredBy Product, By Test Type, By Usability, By Application
 Regions covered
Kanto Region, Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, Shikoku Region
 Companies CoveredAbbott Laboratories, F Hoffmann La Roche, Becton Dickinson & Company, Danaher Corporation, Biomerieux, Bio-rad Laboratories Inc, Thermofisher Scientific Inc, Qiagen, Siemens Healthineers, Sysmex.
COVID-19 Impact on Japan In-Vitro Diagnostics Market
The demand for in-vitro diagnostic products in Japan is expected to rise as a result of the COVID-19 pandemic, due to factors such as increased consumer demand for PCR, NGS, and serology-based rapid-test products, a supportive regulatory environment for drug development and marketing, and a sharp increase in target patient population.

Key Target Audience:
  • Hospitals and Clinical Laboratories
  • Diagnostic Centers
  • Research and Academic Institutes
  • Pharmaceutical and Biotechnology Companies
  • Healthcare Providers and Professionals
  • Government and Regulatory Bodies
  • Patients and General Public
  • Distributors and Suppliers of IVD Products
Our in-depth analysis of the Japan In-Vitro Diagnostics Market includes the following segments:
By Product:
  • Instruments
  • Reagents
  • Others
  • By Test Type:
  • Radiology
  • Pathology
  • Others
  • By Usability:
  • Disposable IVD Devices
  • Reusable IVD Devices
  • By Application:
  • Infectious Disease
  • Diabetes
  • Cancer/Oncology
  • Cardiology
  • Autoimmune Disease
  • Nephrology
  • Other Applications
  • Key Topics Covered in the Report:
    • Japan In-Vitro Diagnostics Market Size (FY’2024-FY’2033)
    • Overview of Japan In-Vitro Diagnostics Market
    • Segmentation of Japan In-Vitro Diagnostics Market By Product (Instruments, Reagents, Others)
    • Segmentation of Japan In-Vitro Diagnostics Market By Test Type (Radiology, Pathology, Others)
    • Segmentation of Japan In-Vitro Diagnostics Market By Usability (Disposable IVD Devices, Reusable IVD Devices)
    • Segmentation of Japan In-Vitro Diagnostics Market By Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, Other Applications)
    • Statistical Snap of Japan In-Vitro Diagnostics Market
    • Expansion Analysis of Japan In-Vitro Diagnostics Market
    • Problems and Obstacles in Japan In-Vitro Diagnostics Market
    • Competitive Landscape in the Japan In-Vitro Diagnostics Market
    • Impact of COVID-19 and Demonetization on Japan In-Vitro Diagnostics Market
    • Details on Current Investment in Japan In-Vitro Diagnostics Market
    • Competitive Analysis of Japan In-Vitro Diagnostics Market
    • Prominent Players in the Japan In-Vitro Diagnostics Market
    • SWOT Analysis of Japan In-Vitro Diagnostics Market
    • Japan In-Vitro Diagnostics Market Future Outlook and Projections (FY’2024-FY’2033)
    • Recommendations from Analyst `
    1. Introduction
    1.1. Scope of the report 
    1.2. Market segment analysis

    2. Research Methodology
    2.1. Research data source
    2.1.1. Secondary Data
    2.1.2. Primary Data
    2.1.3. SPER’s internal database
    2.1.4. Premium insight from KOL’s
    2.2. Market size estimation
    2.2.1. Top-down and Bottom-up approach
    2.3. Data triangulation

    3. Executive Summary

    4. Market Dynamics
    4.1. Driver, Restraint, Opportunity and Challenges analysis
    4.1.1. Drivers
    4.1.2. Restraints
    4.1.3. Opportunities
    4.1.4. Challenges
    4.2. COVID-19 Impacts of the Japan In-Vitro Diagnostics Market.

    5. Market variable and outlook
    5.1. SWOT Analysis
    5.1.1. Strengths
    5.1.2. Weaknesses
    5.1.3. Opportunities
    5.1.4. Threats
    5.2. PESTEL Analysis
    5.2.1. Political Landscape
    5.2.2. Economic Landscape
    5.2.3. Social Landscape
    5.2.4. Technological Landscape
    5.2.5. Environmental Landscape
    5.2.6. Legal Landscape
    5.3. PORTER’s Five Forces 
    5.3.1. Bargaining power of suppliers
    5.3.2. Bargaining power of buyers
    5.3.3. Threat of Substitute
    5.3.4. Threat of new entrant
    5.3.5. Competitive rivalry
    5.4. Heat Map Analysis

    6. Competitive Landscape
    6.1. Japan In-Vitro Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type 
    6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Japan In-Vitro Diagnostics Market

    7. Japan In-Vitro Diagnostics Market, By Product (USD Million) 2020-2033
    7.1. Japan In-Vitro Diagnostics Market Size, Share and Forecast, By Product, 2020-2026
    7.2. Japan In-Vitro Diagnostics Market Size, Share and Forecast, By Product, 2027-2033
    7.3. Instruments
    7.4. Reagents
    7.5. Others

    8. Japan In-Vitro Diagnostics Market, By Test Type (USD Million) 2020-2033
    8.1. Japan In-Vitro Diagnostics Market Size, Share and Forecast, By Test Type, 2020-2026
    8.2. Japan In-Vitro Diagnostics Market Size, Share and Forecast, By Test Type, 2027-2033
    8.3. Radiology
    8.4. Pathology
    8.5. Others

    9. Japan In-Vitro Diagnostics Market, By Usability (USD Million) 2020-2033
    9.1. Japan In-Vitro Diagnostics Market Size, Share and Forecast, By Usability, 2020-2026
    9.2. Japan In-Vitro Diagnostics Market Size, Share and Forecast, By Usability, 2027-2033
    9.3. Disposable IVD Devices   
    9.4. Reusable IVD Devices 

    10. Japan In-Vitro Diagnostics Market, By Application (USD Million) 2020-2033
    10.1. Japan In-Vitro Diagnostics Market Size, Share and Forecast, By Application, 2020-2026
    10.2. Japan In-Vitro Diagnostics Market Size, Share and Forecast, By Application, 2027-2033
    10.3. Infectious Disease   
    10.4. Diabetes   
    10.5. Cancer/Oncology   
    10.6. Cardiology   
    10.7. Autoimmune Disease   
    10.8. Nephrology   
    10.9. Other Applications

    11. Japan In-Vitro Diagnostics Market Forecast, 2020-2033 (USD Million)
    11.1. Japan In-Vitro Diagnostics Market Size and Market Share

    12. Japan In-Vitro Diagnostics Market, By Region, 2020-2033 (USD Million)
    12.1. Japan In-Vitro Diagnostics Market Size and Market Share By Region (2020-2026)
    12.2. Japan In-Vitro Diagnostics Market Size and Market Share By Region (2027-2033) 
    12.3. Kanto Region
    12.4. Kinki Region
    12.5. Central/ Chubu Region
    12.6. Kyushu-Okinawa Region
    12.7. Tohoku Region
    12.8. Chugoku Region
    12.9. Hokkaido Region
    12.10. Shikoku Region

    13. Company Profile
    13.1. Abbott Laboratories 
    13.1.1. Company details
    13.1.2. Financial outlook
    13.1.3. Product summary 
    13.1.4. Recent developments
    13.2. F Hoffmann La Roche 
    13.2.1. Company details
    13.2.2. Financial outlook
    13.2.3. Product summary 
    13.2.4. Recent developments
    13.3. Becton Dickinson & Company 
    13.3.1. Company details
    13.3.2. Financial outlook
    13.3.3. Product summary 
    13.4. Rec Danaher Corporation 
    13.4.1. Company details
    13.4.2. Financial outlook
    13.4.3. Product summary 
    13.4.4. Recent developments
    13.5. Biomerieux 
    13.5.1. Company details
    13.5.2. Financial outlook
    13.5.3. Product summary 
    13.5.4. Recent developments
    13.6. Bio-rad Laboratories Inc
    13.6.1. Company details
    13.6.2. Financial outlook
    13.6.3. Product summary 
    13.6.4. Recent developments
    13.7. Thermofisher Scientific Inc
    13.7.1. Company details
    13.7.2. Financial outlook
    13.7.3. Product summary 
    13.7.4. Recent developments
    13.8. Qiagen 
    13.8.1. Company details
    13.8.2. Financial outlook
    13.8.3. Product summary 
    13.8.4. Recent developments
    13.9. Siemens Healthineers 
    13.9.1. Company details
    13.9.2. Financial outlook
    13.9.3. Product summary 
    13.9.4. Recent developments
    13.10. Sysmex 
     
    14. Conclusion

    15. List of Abbreviations

    16. Reference Links

    SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

    The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

    SPER-Methodology-1

    SPER-Methodology-2

    SPER-Methodology-3


    Frequently Asked Questions About This Report
    Japan In-Vitro Diagnostics Market size is USD 6.70 billion from 2024 to 2033.
    Japan In-Vitro Diagnostics Market Segment is Covered By Product, By Test Type, By Usability, By Application.
    The Asia-Pacific region is anticipated to have the highest market share in Japan In-Vitro Diagnostics Market.
    The key players in the market include Companies Covered Abbott Laboratories, F Hoffmann La Roche, Becton Dickinson & Company, Danaher Corporation, Biomerieux, Bio-rad Laboratories Inc, Thermofisher Scientific Inc, Qiagen, Siemens Healthineers, Sysmex.
    The growing elderly population need more comprehensive and routine medical testing, which is one of the primary reasons driving market growth. In accordance with this, the rising frequency of age-related disorders such as diabetes, cardiovascular disease, and cancer, which necessitates more IVD tests to detect and manage these ailments, is driving market growth.
    Japan In-Vitro Diagnostics Market is projected to reach USD 6.70 billion by 2033, growing at a CAGR of 2.58% during the forecast period.
    Japan In-Vitro Diagnostics Market grew in market size from 2024. The Market is expected to reach 6.70 billion by 2033, at a CAGR of 2.58% during the forecast period.
    Japan In-Vitro Diagnostics Market CAGR of 2.58% during the forecast period.
    Not able to find what you are looking for? Need customization in the existing report?
    Click Here

    Join Our SPER Panel

    Our Global Clients

    Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
    SPER-Astellas Pharma
    SPER-Citi Bank
    SPER-Microsoft
    SPER-EY
    SPER-McKinsey
    SPER-Bain
    SPER-Max-Healthcare
    SPER-DHL
    SPER-SIEMENS
    SPER-IQVIA
    SPER-Pfizer
    SPER-LOREAL
    SPER-Kankar IMRB
    SPER-ITA
    SPER-PWC
    SPER-Sanofi
    SPER-p&g
    SPER-Johnson & Johnson
    SPER-IPSOS
    SPER-Heineken

    SPER

    Market Research

    We are the leading, full-service global market research and consulting company.

    Certificates
    iso-1 iso-1 iso-1 ESOMAR
    Secure Payments
    SPER Payment Options
    Contact HR

     [email protected]

     +91-742-898-5650